Mariëlle Wohlgemuth

Author

Mariëlle Wohlgemuth

Radboud University Nijmegen

Also Known As

Marielle Wohlgemuth, Mariëlle Wohlgemuth

Publications

Citations

H-Index

Concepts

All Affiliations

Radboud University Nijmegen Radboud University Medical Center Leiden University Medical Center Medisch Centrum Leeuwarden Elisabeth-TweeSteden Ziekenhuis

About

Mariëlle Wohlgemuth is an author at Radboud University Nijmegen specializing in medicine, genetics, and neuromuscular pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	6	944
2	Health Sciences	1	1	136
3	Biology	1	1	222
4	Immunology	1	2	206
5	Kinesiology	1	1	136

Mariëlle Wohlgemuth

Publications

912

Citations

H-Index

Page 1

	Year	Citations
Mutations in DNMT3B Modify Epigenetic Repression of the D4Z4 Repeat and the Penetrance of Facioscapulohumeral Dystrophy Marlinde L. van den Boogaard, Richard J.L.F. Lemmers, Judit Balog, The American Journal of Human Genetics ChromatinDevelopmental BiologyMendelian DisorderChromatin RemodelingGenetic Disorder	2016	260
Specific Sequence Variations within the 4q35 Region Are Associated with Facioscapulohumeral Muscular Dystrophy Richard J.L.F. Lemmers, Mariëlle Wohlgemuth, Kristiaan J. van der Gaag, The American Journal of Human Genetics BiologyFacioscapulohumeral Muscular DystrophyRegion Are AssociatedGenetic DisorderMedicine	2007	222
Quantitative MR imaging of individual muscle involvement in facioscapulohumeral muscular dystrophy Hermien E. Kan, Tom W. J. Scheenen, Mariëlle Wohlgemuth, Neuromuscular Disorders Facioscapulohumeral Muscular DystrophyImaging AnatomyKinesiologyMuscle FunctionMedical Imaging	2009	136
Contractions of D4Z4 on 4qB Subtelomeres Do Not Cause Facioscapulohumeral Muscular Dystrophy Richard J F L Lemmers, Mariëlle Wohlgemuth, Rune R. Frants, The American Journal of Human Genetics MedicineGeneticsPhysiologyDegenerative DiseaseNeuromuscular Pathology	2004	120
Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial Christa Walgaard, Bart C. Jacobs, Hester F. Lingsma, The Lancet Neurology ImmunodeficienciesImmunologyPlacebo-controlled TrialPoor PrognosisMultiple Sclerosis	2021	103
A family-based study into penetrance in facioscapulohumeral muscular dystrophy type 1 Mariëlle Wohlgemuth, R. Lemmers, Marianne A. Jonker, Neurology	2018	51
Acupuncture for psychogenic movement disorders: Treatment or diagnostic tool? Bart F.L. van Nuenen, Mariëlle Wohlgemuth, Rudi E. Wong Chung, Movement Disorders	2007	20

Page 1